Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
Blood|April 23, 2015
Excessive antigen reactivity may underlie the clinical aggressiveness of chronic lymphocytic leukemia stereotyped subset #8Maria Gounari, Stavroula Ntoufa, Benedetta Apollonio, et al.
Blood Cells, Molecules & Diseases|October 8, 2020
Increased proportion and altered properties of intermediate monocytes in the peripheral blood of patients with lower risk Myelodysplastic SyndromeMaria Velegraki, Nikos Papakonstantinou, Lydia Kalaitzaki, et al.
Leukemia & Lymphoma|March 11, 2017
The inhibitory receptor toll interleukin-1R 8 (TIR8/IL-1R8/SIGIRR) is downregulated in chronic lymphocytic leukemiaMaria Giovanna Vilia, Eleonora Fonte, Tania Veliz Rodriguez, et al.
Haematologica|July 14, 2011
Toll-like receptor signaling pathway in chronic lymphocytic leukemia: distinct gene expression profiles of potential pathogenic significance in specific subsets of patientsEleni Arvaniti, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
Haematologica|April 28, 2020
Stem cell factor is implicated in microenvironmental interactions and cellular dynamics of chronic lymphocytic leukemiaGeorge I Gavriilidis, Stavroula Ntoufa, Nikos Papakonstantinou, et al.
Epigenetics|November 17, 2012
Distinct transcriptional control in major immunogenetic subsets of chronic lymphocytic leukemia exhibiting subset-biased global DNA methylation profilesMeena Kanduri, Millaray Marincevic, Anna M Halldórsdóttir, et al.
Blood Advances|July 12, 2021
RPS15 mutations rewire RNA translation in chronic lymphocytic leukemiaStavroula Ntoufa, Marina Gerousi, Stamatia Laidou, et al.
Nature Communications|June 10, 2017
Distinct homotypic B-cell receptor interactions shape the outcome of chronic lymphocytic leukaemiaClaudia Minici, Maria Gounari, Rudolf Übelhart, et al.
Blood Advances|March 2, 2022
The TΑp63/BCL2 axis represents a novel mechanism of clinical aggressiveness in chronic lymphocytic leukemiaStamatia Laidou, Dionysios Grigoriadis, Sofia Papanikolaou, et al.
Oncotarget|May 19, 2016
The histone methyltransferase EZH2 as a novel prosurvival factor in clinically aggressive chronic lymphocytic leukemiaNikos Papakonstantinou, Stavroula Ntoufa, Elisavet Chartomatsidou, et al.
Pageof 3